Maha Assi MD in Wichita, Kansas

Home Kansas Wichita

Maha Assi MD has Infectious Disease as her primary medical specialty. Their primary office is: 310 S Hillside St in Wichita, Kansas. There is an additional office location, for a total of two, for Maha Assi MD that can be viewed further down.

They're a part of the: Infectious Disease Consultants, P.a. medical group which has around 25 members. You can call their office at 316-264-3505 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1999 (around 25 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Maha A Assi MD Office Phone and Directions

Maha Assi MD
Infectious Disease Consultants, P.a.
310 S Hillside St
Wichita, Kansas 67211
316-264-3505

Patient Ratings
Please rate your experience with Maha Assi MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 316-264-3505

Enter a starting address:

Healthcare Info for Maha Assi MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 1999
The Primary Medical Specialty for Maha Assi MD is listed as: Infectious Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 25
PAC (PECOS ID)#: 0345277786
NPI #: 1922071224
NPI Created On: 02/08/2006
NPI Last Updated Listed as: 08/03/2021
Primary Taxonomy Code: 207RI0200X
License Number:
04-29896
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Medica Insurance Company
Humana
Blue Cross Blue Shield
Sunflower State Health Plan, Inc
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, French, Spanish, Vietnamese, Arabic.

Services and Procedures include:

Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Removal of tissue from wounds per session
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Injection, ceftriaxone sodium, per 250 mg
Injection, daptomycin, 1 mg
Injection, diphenhydramine hcl, up to 50 mg
Injection, ertapenem sodium, 500 mg
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $20

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 779194191

Being Disputed:: No

Product Related: No

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793931815

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793931819

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793931823

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793931827

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793931831

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793931835

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10

Payments Total: $7

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793931839

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793931843

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793931847

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10

Additional Office Locations

1. Ascension Via Christi Hospitals Wichita Inc
929 N Saint Francis Ave
Wichita, KS 67214
Group Members: 69

Phone: 316-264-3505

Enter a starting address:

Infectious Disease Professionals in Wichita

1.
Jerry Peterie MD

310 S Hillside St
Wichita, KS
Infectious Disease Consultants, P.a.

2.
Thomas Moore MD

310 S Hillside St
Wichita, KS
Infectious Disease Consultants, P.a.

3.
Keck Hartman MD

310 S Hillside St
Wichita, KS
Infectious Disease Consultants, P.a.

4.
Keck Hartman MD

929 N Saint Francis Ave
Wichita, KS
Ascension Via Christi Hospitals Wichita Inc

5.
Paul Brune

3876 N Woodlawn Blvd
Wichita, KS
Metro Infectious Disease Consultants Llc

6.
Margaret Hagan MD

310 S Hillside St
Wichita, KS
Infectious Disease Consultants, P.a.

Providers in Infectious Disease Consultants, P.a.

1.Maha Assi Md

310 S Hillside St
Wichita Ks 67211-2129
Infectious Disease Consultants, P.a.
Infectious Disease

2.Amy Bornholdt Pa

310 S Hillside St
Wichita Ks 67211-2129
Infectious Disease Consultants, P.a.
Physician Assistant

3.Amy Bornholdt Pa

2100 N Waldron St
Hutchinson Ks 67502-1176
Infectious Disease Consultants, P.a.
Physician Assistant

4.Shamara Burrow

310 S Hillside St
Wichita Ks 67211-2129
Infectious Disease Consultants, P.a.
Nurse Practitioner

5.Kristin Constance

310 S Hillside St
Wichita Ks 67211-2129
Infectious Disease Consultants, P.a.
Infectious Disease

6.Kristin Constance

2100 N Waldron St
Hutchinson Ks 67502-1176
Infectious Disease Consultants, P.a.
Infectious Disease

View all 25 members of Infectious Disease Consultants, P.a. medical group